+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer risk



Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer risk



Carcinogenesis 31(10): 1748-1754



Although inflammation is emerging as a candidate prostate cancer risk factor, the T-helper cytokine-rich [interleukins (IL)-5, 13 and 4] chromosomal region at 5q31.1 has been implicated in prostate cancer pathogenesis. In particular, IL-4 has been associated with prostate cancer progression, whereas the IL-4 -589C>T (rs2243250) promoter variant has been associated with differential gene expression. We genotyped rs2243250 and 11 tag single-nucleotide polymorphisms (SNPs) spanning 200 kb across the 5q31.1 region on 825 cases and 732 controls from the Risk Factors for Prostate Cancer Study. The minor alleles of rs2243250 and an IL-4 tagSNP rs2227284 were associated with a small increase in prostate cancer risk. Per allele odds ratios (ORs) are 1.32 [95% confidence interval (CI) 1.08-1.61, P = 0.006] and 1.26 (95% CI 1.07-1.48, P = 0.005), respectively. Although these associations were not replicated in an analysis of the Melbourne Collaborative Cohort Study, including 810 cases and 1733 controls, no clinicopathological characteristic was implicated for this divergence. Correlating rs2243250 genotypes to IL-4 gene transcript levels and circulating IL-4 plasma levels, we observe in contrast to previous reports, a non-significant trend toward the minor T-allele decreasing the likelihood of IL-4 activity. From our observed association between a low IL-4 producing promoter T-allele and prostate cancer risk, our study suggests an antitumor role for IL-4 in prostate cancer. Although we saw no association for IL-5 or IL-13 gene variants and prostate cancer risk, our findings call for further evaluation of IL-4 as a contributor to prostate cancer susceptibility.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269892

Download citation: RISBibTeXText

PMID: 20403914

DOI: 10.1093/carcin/bgq081


Related references

Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer. Human Genetics 126(6): 743-750, 2011

Association of chromosome 8q24 variants with prostate cancer risk in the Siberian region of Russia and meta-analysis. Molekuliarnaia Biologiia 46(2): 234-241, 2012

Expression pattern of a gonadoblastoma candidate gene suggests a role of the Y chromosome in prostate cancer. Cytogenetic and Genome Research 101(3-4): 250-260, 2003

Comprehensive resequence analysis of a 123-kb region of chromosome 11q13 associated with prostate cancer. Prostate 72(5): 476-486, 2012

Computational and biological analysis of 680 kb of DNA sequence from the human 5q31 cytokine gene cluster region. Genome Research 7(5): 495-512, 1997

Variants in the 5q31 cytokine gene cluster are associated with psoriasis. Genes and Immunity 9(2): 176-181, 2007

Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. Human Genetics 134(2): 231-245, 2015

Mutation analysis suggests role for ribonuclease L gene in prostate cancer. Journal of the National Cancer Institute 94(4): 244-245, 2002

Differential expression of a gonadoblastoma candidate gene in gonadoblastoma, testis and prostate cancer suggests a role of the Y chromosome in human oncogenesis. American Journal of Human Genetics 73(5): 229, November, 2003

A comprehensive screen for SNP associations on chromosome region 5q31-33 in Swedish/Norwegian celiac disease families. European Journal of Human Genetics 15(9): 980-987, 2007

A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium. International Journal of Cancer 142(6): 1182-1188, 2017

Localization of a prostate cancer predisposition gene to an 880-kb region on chromosome 22q12.3 in Utah high-risk pedigrees. Cancer Research 66(20): 10205-10212, 2006

Association between genetic variants in glutathione peroxidase 1 gene and risk of prostate cancer: a meta-analysis. Molecular Biology Reports 39(9): 8615-8619, 2012

A Systematic Review and Meta-Analysis of Three Gene Variants Association with Risk of Prostate Cancer: An Update. Urology Journal 12(3): 2138-2147, 2016

Associations of multi-locus genotypes in the cytokine gene cluster on chromosome 5q31-35 in asthmatic patients in Iceland. European Journal of Human Genetics 9(Supplement 1): P1244, 2001